Market Research Logo

Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review

Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fasciitis among others. It also provides RT001, a topical gel formulation of daxibotulinumtoxinA, which is designed to eliminate the use of needles. Revance Therapeutics develops products for multiple aesthetic and therapeutic applications. The company utilizes TransMTS platform technology for the development of its products. It offers products for dermatology, neurology, musculoskeletal disorders, urology and ophthalmology. Revance Therapeutics is headquartered in Newark, California, the US.

Revance Therapeutics Inc Key Recent Developments

Nov 02,2017: Revance Releases Third Quarter 2017 Results
Sep 06,2017: Revance Appoints Mark Foley to its Board of Directors
Aug 03,2017: Revance Releases Second Quarter 2017 Results
Aug 02,2017: Revance appoints new chief commercial officer and president of Aesthetics & Therapeutics
Aug 01,2017: Revance Therapeutics Expands Leadership Team, Appointing Todd Zavodnick Chief Commercial Officer and President, Aesthetics & Therapeutics

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Revance Therapeutics Inc - Key Facts 5
Revance Therapeutics Inc - Key Employees 6
Revance Therapeutics Inc - Key Employee Biographies 7
Revance Therapeutics Inc - Major Products and Services 8
Revance Therapeutics Inc - History 9
Revance Therapeutics Inc - Company Statement 10
Revance Therapeutics Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Company Overview 14
Revance Therapeutics Inc - Business Description 14
Revance Therapeutics Inc - Corporate Strategy 15
Revance Therapeutics Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
Revance Therapeutics Inc - Strengths 16
Revance Therapeutics Inc - Weaknesses 17
Revance Therapeutics Inc - Opportunities 18
Revance Therapeutics Inc - Threats 19
Revance Therapeutics Inc - Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Revance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Revance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Revance Therapeutics Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Nov 02, 2017: Revance Releases Third Quarter 2017 Results 30
Sep 06, 2017: Revance Appoints Mark Foley to its Board of Directors 31
Sep 06, 2017: Revance Appoints Mark Foley to its Board of Directors 32
Aug 03, 2017: Revance Releases Second Quarter 2017 Results 33
Aug 02, 2017: Revance appoints new chief commercial officer and president of Aesthetics & Therapeutics 34
Aug 01, 2017: Revance Therapeutics Expands Leadership Team, Appointing Todd Zavodnick Chief Commercial Officer and President, Aesthetics & Therapeutics 35
May 09, 2017: Revance Releases First Quarter 2017 Results 36
Feb 27, 2017: Revance Releases Fourth Quarter and Full Year 2016 Results 37
Section 6 – Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43
List of Tables
Revance Therapeutics Inc, Key Facts 5
Revance Therapeutics Inc, Key Employees 6
Revance Therapeutics Inc, Key Employee Biographies 7
Revance Therapeutics Inc, Major Products and Services 8
Revance Therapeutics Inc, History 9
Revance Therapeutics Inc, Subsidiaries 13
Revance Therapeutics Inc, Key Competitors 20
Revance Therapeutics Inc, Ratios based on current share price 21
Revance Therapeutics Inc, Annual Ratios 22
Revance Therapeutics Inc, Annual Ratios (Cont...1) 23
Revance Therapeutics Inc, Interim Ratios 25
Revance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Revance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Revance Therapeutics Inc, Recent Deals Summary 29
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42
List of Figures
Revance Therapeutics Inc, Performance Chart (2012 - 2016) 24
Revance Therapeutics Inc, Ratio Charts 26
Revance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Revance Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report